Last reviewed · How we verify
avutometinib and sotorasib — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
avutometinib and sotorasib (avutometinib and sotorasib) — Verastem, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| avutometinib and sotorasib TARGET | avutometinib and sotorasib | Verastem, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- avutometinib and sotorasib CI watch — RSS
- avutometinib and sotorasib CI watch — Atom
- avutometinib and sotorasib CI watch — JSON
- avutometinib and sotorasib alone — RSS
Cite this brief
Drug Landscape (2026). avutometinib and sotorasib — Competitive Intelligence Brief. https://druglandscape.com/ci/avutometinib-and-sotorasib. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab